The medications are essentially interchangeable, though Wegovys slightly higher maximum dose may produce marginally greater weight loss
Moreover, due to its potent effect on gastrointestinal function, it can lead to delayed gastric emptying and alter intestinal motility
women should discuss existing NICE-approved options such as semaglutide (Wegovy) or tirzepatide (Mounjaro) with their GP
Protocol adjustments If nausea is severe, slow the escalation
A meta-analysis showed that GLP-1RA and SGLT2 inhibitor combination therapy was associated with a greater reduction in HbA1c (0.74%), body weight (1.61 kg), and systolic blood pressure (3.32 mmHg) than SGLT2 inhibitor monotherapy ( Conclusion and Perspectives GLP-1RAs are widely used in the treatment of T2D
Ingredient Interaction Warning: Some ingredients in ColonBroom GLP-1 Booster may interact with certain medications or health conditions